Woodley Farra Manion Portfolio Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-85,252
| Closed | -$2.16M | – | 120 |
|
|
2025
Q1 | $2.16M | Buy |
85,252
+993
| +1% | +$26K | 0.11% | 60 |
|
|
2024
Q4 | $2.24M | Buy |
84,259
+3,028
| +4% | +$82.1K | 0.11% | 59 |
|
|
2024
Q3 | $2.35M | Buy |
81,231
+4,481
| +6% | +$131K | 0.12% | 59 |
|
|
2024
Q2 | $2.15M | Buy |
76,750
+3,265
| +4% | +$89.9K | 0.12% | 59 |
|
|
2024
Q1 | $2.04M | Sell |
73,485
-8,079
| -10% | -$224K | 0.11% | 61 |
|
|
2023
Q4 | $2.35M | Sell |
81,564
-2,969
| -4% | -$89.8K | 0.14% | 58 |
|
|
2023
Q3 | $2.8M | Sell |
84,533
-3,809
| -4% | -$135K | 0.19% | 55 |
|
|
2023
Q2 | $3.24M | Sell |
88,342
-1,514
| -2% | -$58.9K | 0.21% | 53 |
|
|
2023
Q1 | $3.67M | Sell |
89,856
-6,302
| -7% | -$272K | 0.25% | 52 |
|
|
2022
Q4 | $4.93M | Sell |
96,158
-5,174
| -5% | -$248K | 0.36% | 40 |
|
|
2022
Q3 | $4.43M | Sell |
101,332
-179
| -0.2% | -$8.7K | 0.36% | 41 |
|
|
2022
Q2 | $5.32M | Buy |
101,511
+384
| +0.4% | +$19.6K | 0.43% | 33 |
|
|
2022
Q1 | $5.24M | Sell |
101,127
-2,487
| -2% | -$129K | 0.39% | 37 |
|
|
2021
Q4 | $6.12M | Buy |
103,614
+6,833
| +7% | +$339K | 0.43% | 34 |
|
|
2021
Q3 | $4.16M | Sell |
96,781
-8,401
| -8% | -$372K | 0.34% | 41 |
|
|
2021
Q2 | $4.12M | Buy |
105,182
+1,089
| +1% | +$42.3K | 0.32% | 48 |
|
|
2021
Q1 | $3.77M | Sell |
104,093
-14,753
| -12% | -$524K | 0.32% | 47 |
|
|
2020
Q4 | $4.38M | Buy |
118,846
+5,675
| +5% | +$208K | 0.39% | 43 |
|
|
2020
Q3 | $3.94M | Sell |
113,171
-17,943
| -14% | -$629K | 0.41% | 37 |
|
|
2020
Q2 | $4.07M | Sell |
131,114
-758
| -0.6% | -$25.8K | 0.43% | 38 |
|
|
2020
Q1 | $4.08M | Sell |
131,872
-4,076
| -3% | -$139K | 0.49% | 32 |
|
|
2019
Q4 | $5.05M | Buy |
135,948
+3,410
| +3% | +$121K | 0.47% | 35 |
|
|
2019
Q3 | $4.52M | Buy |
132,538
+2,264
| +2% | +$82.3K | 0.46% | 38 |
|
|
2019
Q2 | $5.35M | Buy |
130,274
+1,322
| +1% | +$52.5K | 0.54% | 29 |
|
|
2019
Q1 | $5.2M | Sell |
128,952
-5,715
| -4% | -$229K | 0.56% | 27 |
|
|
2018
Q4 | $5.58M | Sell |
134,667
-10,001
| -7% | -$415K | 0.68% | 27 |
|
|
2018
Q3 | $6.05M | Sell |
144,668
-3,791
| -3% | -$146K | 0.63% | 28 |
|
|
2018
Q2 | $5.11M | Buy |
148,459
+576
| +0.4% | +$19.7K | 0.57% | 35 |
|
|
2018
Q1 | $4.98M | Buy |
147,883
+1,675
| +1% | +$57.6K | 0.56% | 35 |
|
|
2017
Q4 | $5.02M | Buy |
146,208
+757
| +0.5% | +$25.8K | 0.55% | 37 |
|
|
2017
Q3 | $4.93M | Buy |
145,451
+1,294
| +0.9% | +$41.6K | 0.57% | 34 |
|
|
2017
Q2 | $4.59M | Buy |
144,157
+2,713
| +2% | +$85.6K | 0.59% | 34 |
|
|
2017
Q1 | $4.59M | Buy |
141,444
+16,977
| +14% | +$535K | 0.6% | 34 |
|
|
2016
Q4 | $3.84M | Buy |
124,467
+12,055
| +11% | +$368K | 0.52% | 37 |
|
|
2016
Q3 | $3.61M | Buy |
112,412
+299
| +0.3% | +$10K | 0.53% | 36 |
|
|
2016
Q2 | $3.75M | Buy |
112,113
+4,329
| +4% | +$138K | 0.58% | 31 |
|
|
2016
Q1 | $3.03M | Buy |
107,784
+24,698
| +30% | +$705K | 0.5% | 34 |
|
|
2015
Q4 | $2.54M | Buy |
83,086
+4,800
| +6% | +$151K | 0.45% | 32 |
|
|
2015
Q3 | $2.33M | Sell |
78,286
-547
| -0.7% | -$17.5K | 0.47% | 30 |
|
|
2015
Q2 | $2.51M | Buy |
78,833
+1,171
| +2% | +$38.2K | 0.48% | 28 |
|
|
2015
Q1 | $2.56M | Buy |
77,662
+2,889
| +4% | +$91.8K | 0.45% | 29 |
|
|
2014
Q4 | $2.21M | Buy |
74,773
+918
| +1% | +$26.3K | 0.4% | 28 |
|
|
2014
Q3 | $2.07M | Buy |
73,855
+1,868
| +3% | +$52.4K | 0.39% | 31 |
|
|
2014
Q2 | $2.03M | Buy |
71,987
+565
| +0.8% | +$16.1K | 0.38% | 32 |
|
|
2014
Q1 | $2.18M | Sell |
71,422
-21,307
| -23% | -$635K | 0.43% | 29 |
|
|
2013
Q4 | $2.69M | Buy |
92,729
+207
| +0.2% | +$6.03K | 0.49% | 29 |
|
|
2013
Q3 | $2.52M | Buy |
92,522
+26,568
| +40% | +$723K | 0.52% | 29 |
|
|
2013
Q2 | $1.75M | Buy |
+65,954
| New | +$1.82M | 0.38% | 32 |
|
Other funds holding PFE
Woodley Farra Manion Portfolio Management's PFE Position: Q2 2025 in Review
Woodley Farra Manion Portfolio Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 85,252 shares — an estimated $2.16M sold.
Woodley Farra Manion Portfolio Management first reported a position in PFE in Q2 2013 and held it in 48 quarters. The position peaked at $6.12M in Q4 2021. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Woodley Farra Manion Portfolio Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Woodley Farra Manion Portfolio Management sold 85,252 Pfizer shares in Q2 2025, an estimated $2.16M.
- Woodley Farra Manion Portfolio Management first reported a position in Pfizer in Q2 2013 and held it in 48 quarters.
- Woodley Farra Manion Portfolio Management's Pfizer position peaked at $6.12M in Q4 2021.
- 2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Woodley Farra Manion Portfolio Management's 13F filing for Q2 2025, filed 8 Aug 2025.